Showing results (1071-1080 of 31,339) with videos related to
Sort By:
Pageof 3,134
Journal of Medicinal Chemistry|August 26, 2021
Discovery of First-in-Class Peptidomimetic Neurolysin Activators Possessing Enhanced Brain Penetration and StabilityMd Shafikur Rahman, Shikha Kumari, Shiva Hadi Esfahani, et al.Journal of Medicinal Chemistry|May 24, 2021
Inhibition of the Oxygen-Sensing Asparaginyl Hydroxylase Factor Inhibiting Hypoxia-Inducible Factor: A Potential Hypoxia Response Modulating StrategyYue Wu, Zhihong Li, Michael A McDonough, et al.Journal of Medicinal Chemistry|August 12, 2021
Synthetic Glycolipids as Molecular Vaccine Adjuvants: Mechanism of Action in Human Cells and In Vivo ActivityFabio A Facchini, Alberto Minotti, Andrea Luraghi, et al.Journal of Medicinal Chemistry|August 13, 2021
Discovery of ASTX029, A Clinical Candidate Which Modulates the Phosphorylation and Catalytic Activity of ERK1/2Tom D Heightman, Valerio Berdini, Luke Bevan, et al.Journal of Medicinal Chemistry|August 20, 2021
1,3-Diarylpyrazolyl-acylsulfonamides as Potent Anti-tuberculosis Agents Targeting Cell Wall Biosynthesis in Mycobacterium tuberculosisLutete Peguy Khonde, Rudolf Müller, Grant A Boyle, et al.Journal of Medicinal Chemistry|August 20, 2021
Pharmacophore-Based Design of Phenyl-[hydroxycyclohexyl] Cycloalkyl-Carboxamide Mitofusin Activators with Improved Neuronal ActivityXiawei Dang, Sidney B Williams, Sriram Devanathan, et al.Journal of Medicinal Chemistry|May 24, 2021
Structure-Based Design and Development of Chemical Probes Targeting Putative MOR-CCR5 Heterodimers to Inhibit Opioid Exacerbated HIV-1 InfectivityBoshi Huang, Huiqun Wang, Yi Zheng, et al.Journal of Medicinal Chemistry|August 3, 2021
Azide-Dye Unexpected Bone Targeting for Near-Infrared Window II Osteoporosis ImagingXiaoqing Zhang, Aiyan Ji, Zhiming Wang, et al.Journal of Medicinal Chemistry|August 3, 2021
Are Pt(IV) Prodrugs That Release Combretastatin A4 True Multi-action Prodrugs?Claudia Schmidt, Tomer Babu, Hana Kostrhunova, et al.Journal of Medicinal Chemistry|June 20, 2020
Structure-Based Drug Discovery of N-((R)-3-(7-Methyl-1H-indazol-5-yl)-1-oxo-1-(((S)-1-oxo-3-(piperidin-4-yl)-1-(4-(pyridin-4-yl)piperazin-1-yl)propan-2-yl)amino)propan-2-yl)-2'-oxo-1',2'-dihydrospiro[piperidine-4,4'-pyrido[2,3-d][1,3]oxazine]-1-carboxamide (HTL22562): A Calcitonin Gene-Related Peptide Receptor Antagonist for Acute Treatment of MigraineSarah J Bucknell, Mark A Ator, Alastair J H Brown, et al.Pageof 3,134